The $0.43 Is The Price At Which Syra Health Corp (NASDAQ: SYRA) Deserves Consideration

During the last session, Syra Health Corp (NASDAQ:SYRA)’s traded shares were 0.62 million, with the beta value of the company hitting 4.92. At the end of the trading day, the stock’s price was $0.43, reflecting an intraday gain of 2.40% or $0.01. The 52-week high for the SYRA share is $8.37, that puts it down -1846.51 from that peak though still a striking 20.93% gain since the share price plummeted to a 52-week low of $0.34. The company’s market capitalization is $4.22M, and the average intraday trading volume over the past 10 days was 0.19 million shares, and the average trade volume was 205.51K shares over the past three months.

Syra Health Corp (NASDAQ:SYRA) trade information

Syra Health Corp (SYRA) registered a 2.40% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 2.40% in intraday trading to $0.43, hitting a weekly high. The stock’s 5-day price performance is 6.46%, and it has moved by 10.79% in 30 days. Based on these gigs, the overall price performance for the year is -64.75%. The short interest in Syra Health Corp (NASDAQ:SYRA) is 0.21 million shares and it means that shorts have 1.39 day(s) to cover.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Syra Health Corp (SYRA) estimates and forecasts

Statistics show that Syra Health Corp has underperformed its competitors in share price, compared to the industry in which it operates. Syra Health Corp (SYRA) shares have gone down -70.54% during the last six months, with a year-to-date growth rate less than the industry average at -43.33% against 24.40. In the rating firms’ projections, revenue will increase 44.90% compared to the previous financial year.

As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 2.01M as predicted by 1 analyst(s).

While earnings are projected to return 11.67% in 2024.

SYRA Dividends

Syra Health Corp is due to release its next quarterly earnings on 2024-Oct-29. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.